Stanford University Cancer Center — Palo Alto, California

Stanford University Cancer Center is a clinical research site located in Palo Alto, California, United States 94305.

Crixeo Health Trust Score: 62/100 (FAIR). This profile has not yet been claimed by the site owner.

Stanford University Cancer Center has participated in 3 clinical trials with 1 currently active.

Therapeutic areas: Primary Amyloidosis, Glioblastoma, Glioblastoma Multiforme.

Sponsors: Prothena Biosciences Ltd., BPGbio, NewLink Genetics Corporation.

Sponsor Feasibility Report

Trust Score: 62/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Stanford University Cancer Center?

Stanford University Cancer Center has a Crixeo Trust Score of 62/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Stanford University Cancer Center conducted?

Stanford University Cancer Center has 3 clinical trials on record, with 1 currently active. Their work covers Primary Amyloidosis, Glioblastoma, Glioblastoma Multiforme.

Is Stanford University Cancer Center accredited by Crixeo Health?

Stanford University Cancer Center has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Stanford University Cancer Center?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.